MedPath

Efficacy of Vonoprazan based therapy (Vonoprazan, Amoxycillin, Levofloxacin) versus Omeprazole based standard therapy for Helicobacter Pylori: A Multicenter Randomized Controlled Trial

Phase 2
Conditions
Helicobacter pylori infection
Eradication rate
Registration Number
TCTR20221226002
Lead Sponsor
Phramongkutklao hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
nknown
Sex
All
Target Recruitment
158
Inclusion Criteria

Patients older than 20 year olds with H.pylori infection

Exclusion Criteria

History of H.pylori eradication
Drug allergy to amoxycillin, clarithromycin, levofloxacin, omeprazole or vonoprazan
Pregnancy or lactation
HIV infection patient
Active UGIB
Hemodynamic unstability
History of gastric cancer or surgery
Chronic lung disease
Active Tuberculosis infection

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath